RT Journal Article
SR Electronic
T1 Reccurent guillain barré syndrome after COVID-19
JF Neurosciences Journal
JO Neurosciences (Riyadh)
FD Prince Sultan Military Medical City
SP 273
OP 276
DO 10.17712/nsj.2023.4.20230012
VO 28
IS 4
A1 Svetlana D. Miletic Drakulic
A1 Snezana R. Lazarevic
A1 Ivana P. Miloradovic
A1 Vladimir S. Jankovic
YR 2023
UL http://nsj.org.sa/content/28/4/273.abstract
AB Coronavirus disease 19 (COVID-19) is known to manifest itself predominantly with respiratory symptoms. However, previous experiences with this disease and many scientific studies have drawn attention to its neurological manifestations. The link between COVID-19 and many neurological diseases, including Guillain Barré syndrome (GBS), has been pointed out. Although GBS is considered a monophasic disease, its relapses occur in 2–6% of cases. We present the case of a female patient with recurrent GBS caused by COVID-19. Given that 2–6% of patients experience a relapse of GBS, and that the COVID-19 pandemic is recognized as a possible trigger of the relapse, we emphasize the importance of intensive neurological monitoring for patients diagnosed with COVID-19 who have a history of GBS.